NHS England Low Priority Treatment - omega-3 fatty acid compounds

Below are the database queries which are used to create this measure. These are run against a copy of the BSA prescribing data which we store in Google BigQuery. We're working on making our BigQuery tables publicly available at which point it will be possible to run and modify these queries yourself. But even where code and database queries are not directly useable by others we believe it is always preferable to make them public.

Description Cost of omega-3 fatty acid compounds per 1000 patients
Why it matters Omega-3 fatty acid compounds are licensed to treat elevated triglycerides, but evidence of benefit is weak. NICE recommend that they are not prescribed for primary prevention of cardiovascular disease.
Tags Cardiovascular system, Cost Saving, Efficacy, NHS England Investment and Impact Fund, NHS England Low Priority, NICE
Implies cost savings Yes
History View change history on GitHub →

Numerator SQL

SELECT
     CAST(month AS DATE) AS month,
     practice AS practice_id,
     SUM(actual_cost) AS numerator
 FROM hscic.normalised_prescribing
 WHERE bnf_code IN ("0212000ABAAAAAA", "0212000ABBBAAAA", "0212000ABBCAAAA", "0212000ABBDAAAA", "0212000ABBEAAAA", "0212000ABBFAAAA", "0212000ABBGAAAA", "0212000ABBHAAAA", "0212000ABBIAAAA", "0212000ABBJAAAA", "0212000V0AAAAAA", "0212000V0AAABAB", "0212000V0BBAAAA", "0212000V0BBABAB")
 GROUP BY month, practice_id

Denominator SQL

SELECT
     CAST(month AS DATE) AS month,
     practice AS practice_id,
     SUM(total_list_size / 1000.0) AS denominator
 FROM hscic.practice_statistics
 GROUP BY month, practice_id